Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Stock Forecast

Stock Price Forecast

The 20 analysts with 12-month price forecasts for Edwards Lifesciences stock have an average target of 79.25, with a low estimate of 60 and a high estimate of 90. The average target predicts an increase of 5.39% from the current stock price of 75.20.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$60	$79.25	$80	$90
Change	-20.21%	+5.39%	+6.38%	+19.68%

Analyst Ratings

The average analyst rating for Edwards Lifesciences stock from 20 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	4	5	6	6	6	5
Buy	4	4	4	4	4	5
Hold	13	12	10	10	10	9
Sell	0	0	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	21	21	21	21	21	20

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Adam Maeder Piper Sandler	Piper Sandler	Hold → Buy Upgrades $73 → $80	Hold → Buy	Upgrades	$73 → $80	+6.38%	Apr 24, 2025
David Rescott Baird	Baird	Hold Maintains $72 → $75	Hold	Maintains	$72 → $75	-0.27%	Apr 24, 2025
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $78 → $75	Hold	Maintains	$78 → $75	-0.27%	Apr 11, 2025
Matt Miksic Barclays	Barclays	Buy Maintains $88 → $90	Buy	Maintains	$88 → $90	+19.68%	Feb 13, 2025
William Plovanic Canaccord Genuity	Canaccord Genuity	Hold Maintains $68 → $71	Hold	Maintains	$68 → $71	-5.59%	Feb 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

5.99B

Increased by 10.07%

from 5.44B

Revenue Next Year

6.57B

Increased by 9.65%

from 5.99B

EPS This Year

2.54

Decreased by -63.61%

from 6.97

EPS Next Year

2.84

Increased by 11.91%

from 2.54

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	4.39B	5.23B	4.46B	5.01B	5.44B	5.99B	6.57B	7.25B
Revenue Growth	0.88%	19.29%	-14.69%	12.23%	8.57%	10.07%	9.65%	10.50%
EPS	1.30	2.38	2.44	2.30	6.97	2.54	2.84	3.19
EPS Growth	-20.73%	83.08%	2.40%	-5.44%	202.39%	-63.61%	11.91%	12.36%
Forward PE	-	-	-	-	-	29.65	26.50	23.58
No. Analysts	-	-	-	-	-	39	36	25

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	6.2B	6.9B	7.7B
Avg	6.0B	6.6B	7.3B
Low	5.6B	6.1B	6.5B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	14.4%	14.6%	17.1%
Avg	10.1%	9.7%	10.5%
Low	3.9%	1.5%	-1.4%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	2.93	3.22	3.45
Avg	2.54	2.84	3.19
Low	2.36	2.52	2.70

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-58.0%	27.1%	21.6%
Avg	-63.6%	11.9%	12.4%
Low	-66.1%	-0.7%	-5.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.